News
Genentech’s Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple Sclerosis - Patients on ...
The heat can also trigger migraines either directly, by affecting thermoregulatory processes in the brain, or indirectly, by ...
Sunshine may hold healing rays for a variety of autoimmune diseases such as multiple sclerosis. Scientists are turning this ...
Before making changes to your diet, it’s a good idea to speak to your doctor or a qualified dietitian to make sure you don’t ...
This mysterious autoimmune disease presents with over 100 different symptoms, making diagnosis incredibly challenging for ...
Is genetically modified wheat behind rising health issues? Dr Ashwini Setya decodes the impact and alternatives for a ...
Cohort analyses from the WILLOW study reveal clear proof of concept in patients with CLE and SLE with active lupus rash, showing clinically meaningful ...
Patients on fenebrutinib had low relapse rates with data showing no active brain lesions or disability progression after nearly two years of treatment - - Phase III studies for fenebrutinib in ...
Background: Multiple sclerosis (MS) is an autoimmune ... Treatment with lamotrigine was associated with more rashes (20% vs 5%, P value 0.03) and transient, dose-related deterioration of mobility (66% ...
Researchers from the University of California San Diego School of Medicine have discovered that children living with multiple ...
6d
Onlymyhealth on MSNMultiple Sclerosis Risk: What Is The Age Of Onset?Multiple Sclerosis (MS) is a lifelong condition that affects the brain and spinal cord, disrupting communication between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results